MOLN compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name

MOLNMolecular Partners AG

Mkt capRevenueRevenue

BNTCBenitec Biopharma Inc.

Mkt capRevenueRevenue

Compare

MOLNMolecular Partners AG

BNTCBenitec Biopharma Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

MOLNMolecular Partners AG

3.98▲+11.17%· post 3.71

Mkt cap$144.5MRevenue—

BNTCBenitec Biopharma Inc.

8.77▼−0.67%· post 8.77

ClosedOct 30 '26

Mkt cap$304.9MRevenue$7,000Q4 FY23

Compare

ClosedOct 30 '26

MOLNMolecular Partners AG

BNTCBenitec Biopharma Inc.

3.98▲+11.17%post 3.71

Price

8.77▼−0.67%post 8.77

$144.5M

Mkt cap

$304.9M

—

Revenue

$7,000Q4 FY23

MOLN3.98▲+11.17%vsBNTC8.77▼−0.67%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

MOLN: latest quarter not drawable. BNTC: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MOLN 1

—Orano Medunlistedsupplier

Shared 0

No shared counterparties.

Only BNTC 2

—Australian governmentunlistedsupplier

—Axovant Therapeuticsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

MOLN, solidBNTC, dashed